Pages that link to "Q58301889"

The following pages link to Aleksandra Szymczak (Q58301889):

Displaying 42 items.

• Osteoporosis in Gastrointestinal Diseases (Q26764988) (← links)
• Comorbidities as risk factors of chronic kidney disease in HIV-infected persons (Q26775680) (← links)
• Shear wave elastography of the spleen: evaluation of spleen stiffness in healthy volunteers (Q30371740) (← links)
• Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults (Q34387456) (← links)
• Is faecal calprotectin equally useful in all Crohn's disease locations? A prospective, comparative study (Q35582808) (← links)
• Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodies (Q35627602) (← links)
• Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures (Q35819904) (← links)
• The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity (Q36095803) (← links)
• The importance of vitamin D in the pathology of bone metabolism in inflammatory bowel diseases (Q36220669) (← links)
• Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease. (Q36747140) (← links)
• Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn's disease naive to anti-TNF agents (Q37306556) (← links)
• Co-Infection of the Hepatitis C Virus With Other Blood-Borne and Hepatotropic Viruses Among Hemophilia Patients in Poland. (Q37383718) (← links)
• Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease. (Q37396629) (← links)
• Diagnostic importance of faecal markers in long-term monitoring of anti-TNF-α therapy in primary responders with Crohn's disease (Q37553641) (← links)
• Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics. (Q38675771) (← links)
• Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype. (Q39338033) (← links)
• Time trends in HIV-1 transmitted drug resistance mutation frequency in Poland (Q39338048) (← links)
• Stage of liver fibrosis in patients with congenital bleeding disorders and infected with hepatitis C virus. (Q40191199) (← links)
• Association of serum VEGF with clinical response to anti-TNFα therapy for Crohn's disease (Q40415878) (← links)
• The diagnostic usefulness of fecal lactoferrin in the assessment of Crohn's disease activity. (Q40710648) (← links)
• Replication of hepatitis C virus in peripheral blood mononuclear cells in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. (Q42265297) (← links)
• Tubo-ovarian abscess during therapy of chronic hepatitis C with pegylated interferon and ribavirin (Q43637251) (← links)
• Identifying pre-existing NS3 and NS5A resistance-associated variants and transmission chains in the Polish HIV/HCV genotype 1 epidemic: impact on prevention and treatment. (Q47553101) (← links)
• Three episodes of brain stroke as a manifestation of neurosyphilis in an HIV-infected man. (Q48342626) (← links)
• Current opportunities for treatment of chronic hepatitis C in patients with HIV co-infection (Q50567423) (← links)
• Molecular virology and treatment of patients with chronic hepatitis C (Q50577905) (← links)
• Association between disease duration and usefulness of fecal calprotectin measurement in patients with Crohn's disease. (Q54349711) (← links)
• Krzysztof Simon (Q57262045) (← links)
• Hepatitis C virus (HCV) genotype 1 NS5A resistance-associated variants are associated with advanced liver fibrosis independently of HCV-transmission clusters (Q59357466) (← links)
• [The role of therapeutic use of interleukin-2 in HIV infection] (Q73195476) (← links)
• [Unsolved problem of current hepatology: the diagnosis and therapy of autoimmune overlap syndrome] (Q73705533) (← links)
• [Natural history of the HIV infection and changes in the central nervous system] (Q74652497) (← links)
• [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count] (Q80170977) (← links)
• [Assessment and monitoring of patients with chronic hepatitis C on antiviral therapy--state of the art in 2003] (Q80964583) (← links)
• Pathogenesis and methods evaluation of liver fibrosis in HIV/HCV co-infection (Q83802604) (← links)
• Calcium and phosphate metabolism in patients with inflammatory bowel diseases (Q85601447) (← links)
• Interchangeability of 3 recombinant anti-HBV vaccines in primary schedule, irrespective of dose and HBsAg subtype: the first prospective, open-label, randomized study in healthy adult population (Q86060156) (← links)
• Risk factors for chronic kidney disease do not influence the serum levels of asymmetric dimethylarginine in HIV-1-infected patients without significant renal disease (Q88148950) (← links)
• [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature] (Q95490185) (← links)
• Diversity of Growth Responses of Soil Saprobic Fungi to Recurring Heat Events (Q97420712) (← links)
• Assessment of urinary cystatin C levels in HIV-1-infected patients with preserved kidney function (Q124428841) (← links)
• Assessment of urinary cystatin C levels in HIV-1-infected patients with preserved kidney function (Q124428863) (← links)